Investors FAQ

Where are you located?

Torqur AG
c/o Swiss Rockets AG
Rittergasse 3, 4051 Basel

Can you provide a brief description of your company?

Torqur is a Swiss clinical-stage biotech company launched in 2021 as a subsidiary of Swiss Rockets, a Basel-based incubator and accelerator of start-up companies in oncology and infectiology. 

Torqur is establishing the platform for the discovery and efficient development of innovative anti-cancer therapies targeting the metabolic PI3K/mTOR intracellular signalling pathway.


When was the company founded?

Torqur AG was founded in 2021 in Basel, Switzerland.

Can I buy shares directly from Torqur AG?

Yes, you can buy shares of Torqur AG  if you are a qualified private or institutional investor.
For more information, contact us at

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. At Torqur, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe from the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Torqur to send you the requested Investor Email Alert updates.